3,5-Dichloro-2'-(thiomethyl)benzophenone, 97.0%, 1g

1-Boc-5-Bromo-3-iodo-1H-indazole, 96.0%, 1g

2-Fluoro-6-hydroxybenzonitrile>98.0%(GC)(T)1g

Filtres pour seringues Minisart® NML avec marquage CE Stérile (stérilisé par gamma), 0,45 µm, 50 Pièce(s)

2-[(6-methylpyridazin-3-yl)oxy]acetic acid, 95.0%, 250mg

2-Bromo-6-fluoro-4-methylpyridine, 95.0%, 250mg

2-Carboethoxy-4'-morpholinomethyl benzophenone, 97.0%, 1g

Methanesulfonato(2-dicyclohexylphosphino-3,6-dimethoxy-2',4',6'-tri-i-propyl-1,1'-biphenyl)(2'-amino-1,1'-biphenyl-2-yl)palladium(II), 98%, 100mg

2'-OMe-Ac-C Phosphoramidite, 5g

N-(1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)acetamide, 95%, 5g

4-methoxy-6-oxo-1-phenyl-1,6-dihydropyridazine-3-carboxylic acid, 95.0%, 500mg

Lithium acetylacetonate, 97%, 25g

tert-Butyl (1S,2R,4S,5R)-7-oxo-3-oxa-6-azatricyclo[3.2.1.02,4]octane-6-carboxylate, 95%, 100mg